Shop in new york as we continue our focus here on the show on Small Business. In fact, this hour we will look at how the owners of this business have survived the sixweek lockdown and also look at the questions about how long they can hold out. Also its may 1st. While were still waiting for the green light here in new york to open up our economy, there are more states that are wraf wrafrp that are ramping things up here. We will take you to tennessee and texas later in the hour, where restaurant, stores, even theaters are starting to open. Coverage of our top stories with fox Business Team coverage, blake burman monitoring the latest coming out of the white house especially on the remdesivir news and Lauren Simonetti watching the markets for us. Thats where we start. Lauren . Not a good day to watch the markets, connell. Sharp losses on wall street on this first trading day of may. There are two issues for investors today, two big ones, trade and technology. President trump threatening new tariffs on china for its handling of coronavirus and some of the companies that have outperformed during the pandemic showing that even they are not immune to it. But lets take a look at numbers for the week. It looks a lot better than it did today. Relatively modest losses across the board this week. Now, take a look at amazon shares. Record close yesterday. Today down sharply. The Company Reported earnings, said they are going to spend 4 billion dollars on testing and delivery, but over a dozen analysts raised their price targets on the stock today, and that suggests that todays levels could be a buying opportunity, for many, because this is a company that has done well, especially during coronavirus and well this year. Lets take a look at apple, rare move, it pulled its june quarter guidance. It also warned about iphone revenue in this Current Quarter will be impacted. So apple shares are down today as well. No one is placing a bet on the casino stocks. Macau gaming revenue plummeting almost 97 in april. And these stocks got hammered as a result. Next week, disney and peloton, two of the big stocks reporting, they have been beneficiaries of these stay at home orders that are slowly lifting across the nation. We will see what they have to say about the viruss impact and how they will move the markets quite honestly, also help to determine if sell in may and go away rings true this year. On this 1st day of may, not a good one. Back to you connell and melissa. Connell no, not at all. Thank you, lauren. We have a fox business alert now to the white house we go where President Trump has been meeting with the ceo of Gilead Sciences and we are going to listen in on what the president has to say. Check that. We dont have the president ready yet. It is one of those playback situations. Were awaiting for that news to come. Blake burman is joining us, monitoring things out of the white house as always. As we wait for that, that is fairly significant news, blake, and now indeed ahead of myself, it is happening at the white house. Lets go back there. Heres the president. Companys been in the news, and it is a Great American company thats done incredible work on hiv and hepatitisc. I hear that thats whats happening with hepatitis is a great medical story, a great medical story. I have been hearing about that. Thats fantastic. Im pleased to announce that gilead now has an eua from the fda for remdesivir. You know what that is because thats been the hot thing also in the papers and in the media for the last little while. An important treatment for hospitalized coronavirus patients. And its something i spoke with dr. Khan and dr. Fauci. I spoke with deborah about it, and its really a very promising situation. Weve been doing work with the teams at the fda, nih, and gilead for spearheading this Public Private partnership to make this happen very quickly. So today were going to be im going to let dan do it, but were going to let dan make a statement as to what the company is doing, making a contribution to really people that are not doing well, people that are sick, people who have this horrible plague thats set into our country, and were getting rid of, and were going to be having some really incredible results. We have very promising studies coming out on the vaccines. We have promising studies coming out on therapeutics, and the first one is from dan and gilead. I would like to maybe have you say a few words, if you would, dan, as to number one, about remdesivir to start off with and also the contribution being made by your company, and we very much appreciate it. Sure. Thank you very much, mr. President. Thank you for having us here. Thank you, mr. Vice president for the collaboration that weve had. Let me start by saying on behalf of i know all the colleagues at gilead, we want to thank all the collaborators that brought remdesivir to this point. That includes nih and dr. Fauci and certainly commissioner and many many more people that have been a part of this to bring this to where we are today. And in fact, really the thanks go to the patients and the care givers that participated in these Clinical Trials. I also want to say im privileged to work with a group of amazing scientists at gilead that for decades have been working on antivirals and were poised to put remdesivir immediately into Clinical Trials when we saw the covid19 circulating. So im really proud of the colleagues back at gilead. What id like to say is that on behalf of gilead, to the president s point, we feel a tremendous responsibility. Were humbled by this being an important first step for patients, for hospitalized patients. We want to make sure nothing gets in the way of these patients getting the medicine, so we made a decision to donate about 1. 5 million vials of remdesivir. We will be working with the government to determine how best to distribute that, within the United States. We will be working very closely to get that to patients, working with fema, working with other parts of the government to make sure that we get that to the patients in need as quickly as possible, because there are patients out there that can benefit from this medicine today that are hospitalized, and we dont want any time to waste for that. Were also fully committed to continuing to expand the supply of this medicine. We started investing in this back in january, as soon as we became aware of the coronavirus. This is a long time to manufacture. It used to be 12 months. It is now six months. Our scientists have brought that down. As we get into the second half of this year, were able to have many more supplies available to patients, and were fully committed to working, mr. President , with you, your administration, to make sure that patients that need it can get this important new medicine. I really appreciate it, but i also noticed the incredible job youve done with hiv, which, you know, i remember so well, 15 years ago, 16 years ago, it was a horrible thing. I lived in new york. I lost a lot of friends through hiv. It was terrible. And also hepatitisc. Could you give us just a quick moment on how successful thats been because ive seen things that are pretty incredible that a lot of people dont know. Absolutely. Im reminded with ambassador birx and all her work on this as well. The colleagues at gilead have collaborated for years on the developing world on hiv. It is astonishing. This is one of the reasons why i joined gilead a while ago. The reason i joined is because of this progress. You remember of course back when hiv was a death sentence and now thanks to the sciences of gilead and elsewhere weve turned this into a really chronic disease and also a prevent preventable disease. I want to give the Administration Thanks on the hiv prevention and prep program that were working now and many particularly disadvantaged parts of our country to get more patients on prevention because the best way of course to stop and to end this epidemic is a combination of treatment and prevention. Hepatitisc, im happy to say that the scientists have come up with a cure some years ago, and weve made tremendous progress and including some really creative new arrangements in the United States like with the state of louisiana where weve looked at ways to look at programs to make sure that every patient in a state is able to get the opportunity to be cured. Im very proud that we have this kind of science but also that we put this science in a way that gets access to patients. With hepatitisc, it is an actual cure. It is an actual cure. Yes, 12 week oral therapy cure. I mean were still working on the hiv cure. We havent given up. It is a much more difficult problem. Well probably get some long acting medicines first. More complex problem. Much more complex. Im embarrassed to talk about this in front of ambassador birx. She should talk about this. Its complex to get the virus completely suppressed where would you put coronavirus in that level of complexity . It is earl lil days on coronavirus it is early days on coronavirus. This is the first step today. I think what we will see it may be like with other viruses that we have seen, with this, with an antiviral like remdesivir, that the way to actually even get better results is to add medicines on top of an antiviral. Thats really how we were able to get hiv to a chronic illness by combination therapy. This is the beginning. Theres a lot of Great Companies out there that are working on that were collaborating with, my colleagues in the industry, and were all working together to do everything we can. Its very exciting. A very major contribution towards helping people. We very much appreciate that. Im talking about a monetary contribution as well as more importantly what youre doing scientifically. So we appreciate it very much. Doctor, would you say a few words . The fda has been move things along at a level that they have never done before. And i appreciate it, doctor. Thank you, mr. President. Really appreciate it. So as the president just announced, we authorized gileads application for emergency use authorization for the use of remdesivir in hospitalized patients. And that was issued today. Thank you very much and congratulations for the great work from the company and the collaboration we have had. I also want to thank the more than 18,000 employees at fda who have heeded the president s call to reduce Regulatory Burden and red tape and moved things forward. I think i said the other day this is lightning speed in terms of getting something approved, and from Clinical Trial to getting it authorized from the fda, its been quite the speedy but also effective process. This is an important clinical advance that showed a statistically significant reduction in time to recovery for patients with covid19. And it is the First Authorized therapy for covid19. So were really proud to be a part of it. Mr. President , thank you for your leadership. Thank you. Dr. Hahn left one of the most important jobs in medicine, as you know, to take the fda, and were glad he did. Were grateful. Very important job and a tremendous reputation, but to take this job and youre doing great. Were really proud of you thank you, sir. Deborah, please . I will be very brief. I think this really illustrates what can happen in such a short time. I mean, from the first case that was diagnosed in the United States to now, our first step forward with a therapeutic in less than 90 days, for those of us who have worked in viral diseases and pandemics for a long time, this is our first really positive step forward. Its our first step forward. Obviously groups are still working on vaccines. I just want to also thank the company for not only making sure this got into Clinical Trial, but for individuals who didnt qualify for the Clinical Trial, they made compassionate use drugs available from the very beginning at our request and around the world, and i think that combination of really strong scientific rigor as Clinical Trials but also when you dont really have something to make compassionate use available was also really quite extraordinary, so again, also thank you for the patients because obviously this was a randomized trial. There was a group that did not get the drug. It is why the monitoring board stopped the trial because of this statistical difference because you cant keep placebos on a trial when youve already shown significance in the treatment arm, and so to the patients who were willing to be randomized and to the doctors who did the trials and the nurses who took care of them, were really very grateful because this Clinical Research is critical for these breakthroughs, but obviously theres someone getting the agent and theres others that arent, and so thats really been extraordinary. Thank you very much. While were here, i would like to have alex discuss for a second. We will be aids free as a country and i used to say two years ago ten years and now were down to eight years, and maybe even sooner than that working with gilead and other companies and working with the great people that were dealing with medically in our country. And maybe you could Say Something about that, alex, because nobody knows you could even do that, but were looking to be aids free within the United States within eight years. We started at frankly it could have been started in the Previous Administration and they decided not to, and i decided to do it. Please, alex. Again, it is a bit embarrassing to be talking about hiv aids standing next to dr. Birx. She can correct me as i go. But really thanks to President Trumps leadership, the tools were there. The tools were there to end the hiv epidemic in the United States, but it was the president s call and the state of the Union Address that brought everyone together including this Great Company gilead and the United States government, all of our partners actually end the hiv epidemic. The tools are that you need to diagnose individuals. Part of that is getting people that are in underserved areas. We particularly have africanamerican males in southern rural communities. We have native americans. We have many underserved who are not getting diagnosed. If we can get you diagnosed, we can get you on therapy if you are positive for the disease. And if youre on therapy, and your viral load is undetectable, you are untransmissible. You cant give that virus to somebody else if you stay on therapy, and our Amazing Program has an incredible over 80 percent success rate at getting people who are positive to be undetectable by being compliant with their drug. And then if you are negative, but you have behaviors that put you at risk for getting hiv, you can take prep. You can take the product with compliance keeps you 97 chance that you wont get the hiv disease also. And so the tools are there. It is about execution and blocking and tackling and thats what the president s leading. We have gotten the funding from congress for this. We really have this on our grasp, but the tools were there, but it took President Trumps call to action to make this a reality. My first year in office, i was being briefed and they told me this is a possibility if we wanted to do it, i said who wont want to do this . I said who wouldnt want to do this. . Everything is a lot of money. But this is small money compared what were talking about. I lost a tremendous number of friends to aids, some of the most talented people i knew i lost to aids. It is incredible. Do you have anything to add to it . I mean you are the real expert on aids and the eradication. Anything to add about eradication in our country . We just appreciate the governments support on doing both domestic and global work on hiv aids because obviously you are also investing in the program to bring the same level of compassion and treatment to people around the globe to really control the epidemic around the globe. This is a big step forward for all of us to really what do you think of the timing . Am i right when i say about eight years . Well, were always to actually control the pandemic to make it controllable and smaller, thats absolutely possible. To eradicate it, obviously we need a vaccine or a cure. There are groups working on that under your direction to really ensure how is that coming . Weve made forward progress on vaccines and then a little step back wards and then forward progress. Its tough work. The cure is tough work. Your scientists are working on it around the clock and around the world. Good. That would be terrific. Mike, please. Thank you, mr. President. I just appreciate the opportunity to express the gratitude that we all feel, dan to you and the Incredible Team at gilead. To think of the progress that youve made in such an extraordinary period of time, when the president brought the pharmaceutical companies here to the white house, you were among them. We said you wanted to move out quickly on developing a vaccine, but he said develop the therapeutics as quickly as you can. We were told that it was possible that by the spring we would have therapeutics and standing here on may the 1st, the very first therapeutic with the emergency use authorization, the good work of fda is now available. But donating 1. 5 million doses, our task force will be working very closely with gilead to make sure that those medicines starting on monday are distributed to hospitals where patients are struggling in serious conditions, with the coronavirus today. And so i hope you will carry back our gratitude, but i know the gratitude of the American People when they see the incredible ingenuity and generosity of the team at gilead. God bless you. Thank you very much, mr. Vice president. Appreciate that. And adam, maybe you could say a few words. You were very instrumental in getting this done and also on ventilators, getting us to be the kings and queens of ventilators. We have a lot of ventilators.